278 related articles for article (PubMed ID: 21576825)
1. PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans.
Bezy O; Tran TT; Pihlajamäki J; Suzuki R; Emanuelli B; Winnay J; Mori MA; Haas J; Biddinger SB; Leitges M; Goldfine AB; Patti ME; King GL; Kahn CR
J Clin Invest; 2011 Jun; 121(6):2504-17. PubMed ID: 21576825
[TBL] [Abstract][Full Text] [Related]
2. Diverse roles for protein kinase C delta and protein kinase C epsilon in the generation of high-fat-diet-induced glucose intolerance in mice: regulation of lipogenesis by protein kinase C delta.
Frangioudakis G; Burchfield JG; Narasimhan S; Cooney GJ; Leitges M; Biden TJ; Schmitz-Peiffer C
Diabetologia; 2009 Dec; 52(12):2616-20. PubMed ID: 19809797
[TBL] [Abstract][Full Text] [Related]
3. Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunction.
Kujiraoka T; Satoh Y; Ayaori M; Shiraishi Y; Arai-Nakaya Y; Hakuno D; Yada H; Kuwada N; Endo S; Isoda K; Adachi T
J Am Heart Assoc; 2013 Aug; 2(4):e000361. PubMed ID: 23954796
[TBL] [Abstract][Full Text] [Related]
4. Role of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism.
Li M; Vienberg SG; Bezy O; O'Neill BT; Kahn CR
Diabetes; 2015 Dec; 64(12):4023-32. PubMed ID: 26307588
[TBL] [Abstract][Full Text] [Related]
5. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
6. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
7. Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity.
Rossmeisl M; Rim JS; Koza RA; Kozak LP
Diabetes; 2003 Aug; 52(8):1958-66. PubMed ID: 12882911
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.
Abu-Elheiga L; Wu H; Gu Z; Bressler R; Wakil SJ
J Biol Chem; 2012 Apr; 287(15):12578-88. PubMed ID: 22362781
[TBL] [Abstract][Full Text] [Related]
9. Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse.
Anderson KA; Lin F; Ribar TJ; Stevens RD; Muehlbauer MJ; Newgard CB; Means AR
Mol Endocrinol; 2012 Feb; 26(2):281-91. PubMed ID: 22240810
[TBL] [Abstract][Full Text] [Related]
10. Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis.
Liu N; Yang X; Guo J; Zhang L; Huang S; Chen J; Huang J; Chen Y; Cui T; Zheng Y; Li T; Tang K; Zhong Y; Duan S; Yu L; Tang Y; Zheng D; Pan H; Gao Y
EMBO Rep; 2023 Jun; 24(6):e56390. PubMed ID: 37154299
[TBL] [Abstract][Full Text] [Related]
11. Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice.
Liu BH; Lin YY; Wang YC; Huang CW; Chen CC; Wu SC; Mersmann HJ; Cheng WT; Ding ST
Exp Anim; 2013; 62(4):347-60. PubMed ID: 24172199
[TBL] [Abstract][Full Text] [Related]
12. Pu'erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo lipogenesis in visceral adipose tissue.
Cai X; Hayashi S; Fang C; Hao S; Wang X; Nishiguchi S; Tsutsui H; Sheng J
J Gastroenterol; 2017 Dec; 52(12):1240-1251. PubMed ID: 28364190
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.
Delibegovic M; Zimmer D; Kauffman C; Rak K; Hong EG; Cho YR; Kim JK; Kahn BB; Neel BG; Bence KK
Diabetes; 2009 Mar; 58(3):590-9. PubMed ID: 19074988
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
15. Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
Gao XF; Chen W; Kong XP; Xu AM; Wang ZG; Sweeney G; Wu D
Diabetologia; 2009 May; 52(5):912-20. PubMed ID: 19224198
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
Softic S; Gupta MK; Wang GX; Fujisaka S; O'Neill BT; Rao TN; Willoughby J; Harbison C; Fitzgerald K; Ilkayeva O; Newgard CB; Cohen DE; Kahn CR
J Clin Invest; 2017 Nov; 127(11):4059-4074. PubMed ID: 28972537
[TBL] [Abstract][Full Text] [Related]
17. PKCδ is activated in the liver of obese Zucker rats and mediates diet-induced whole body insulin resistance and hepatocyte cellular insulin resistance.
Greene MW; Burrington CM; Luo Y; Ruhoff MS; Lynch DT; Chaithongdi N
J Nutr Biochem; 2014 Mar; 25(3):281-8. PubMed ID: 24524901
[TBL] [Abstract][Full Text] [Related]
18. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
Sajan MP; Ivey RA; Lee MC; Farese RV
J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
[TBL] [Abstract][Full Text] [Related]
19. Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.
Sajan MP; Nimal S; Mastorides S; Acevedo-Duncan M; Kahn CR; Fields AP; Braun U; Leitges M; Farese RV
Metabolism; 2012 Apr; 61(4):459-69. PubMed ID: 22225955
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the E3 Ubiquitin Ligase IDOL Attenuates Diet-Induced Obesity and Metabolic Dysfunction in Mice.
van Loon NM; Ottenhoff R; Kooijman S; Moeton M; Scheij S; Roscam Abbing RLP; Gijbels MJJ; Levels JHM; Sorrentino V; Berbée JFP; Rensen PCN; Zelcer N
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1785-1795. PubMed ID: 29903737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
